MARKET INSIGHTS

ZTOX Insights

AI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.

185 articles published

KAJARIACER
KAJARIACER
1 min read
Market Updates Corporate announcement

Kajaria Ceramics (KAJARIACER): Company Update

Company Update Pursuant to the provisions of the Listing Regulations, we wish to inform you that the Company (through State Bank of India) has provided Standby Letter of Credit (''SBLC'') of INR 3.75 crores (equivalent to NPR 6 crores) in respect of Term Loan in favour of Everest Bank Limited (Lead Bank of the Consortium of Nepalese Banks) on behalf of Kajaria Ramesh Tiles Limited, Nepal, a Joint Venture Company. Pursuant to the provisions of the Listing Regulations, we wish to inform you that

Read article
KAJARIACER
KAJARIACER
1 min read
Market Updates Corporate announcement

Kajaria Ceramics (KAJARIACER): Giving guarantees/indemnity/ becoming a surety for third party

Giving guarantees/indemnity/ becoming a surety for third party Pursuant to the provisions of the Listing Regulations, we wish to inform you that the Company (through State Bank of India) has provided Standby Letter of Credit ( SBLC ) of INR 3.75 crores (equivalent to NPR 6 crores) in respect of Term Loan in favour of Everest Bank Limited (Lead Bank of the Consortium of Nepalese Banks) on behalf of Kajaria Ramesh Tiles Limited, Nepal, a Joint Venture Company. Pursuant to the provisions of the L

Read article
KAJARIACER
KAJARIACER
1 min read
Market Updates Corporate announcement

Kajaria Ceramics (KAJARIACER): Giving guarantees/indemnity/ becoming a surety for third party

Giving guarantees/indemnity/ becoming a surety for third party Pursuant to the provisions of the Listing Regulations, we wish to inform you that the Company (through State Bank of India) has provided Standby Letter of Credit ( SBLC ) of INR 3.75 crores (equivalent to NPR 6 crores) in respect of Term Loan in favour of Everest Bank Limited (Lead Bank of the Consortium of Nepalese Banks) on behalf of Kajaria Ramesh Tiles Limited, Nepal, a Joint Venture Company. Pursuant to the provisions of the L

Read article
CONCORDBIO
CONCORDBIO
1 min read
Market Updates Corporate announcement

Concord Biotech Receives USFDA Approval for Mycophenolate Mofetil Suspension

Concord Biotech has secured USFDA approval for its Mycophenolate Mofetil for Oral Suspension USP, marking a key regulatory milestone for the company.

Read article
CONCORDBIO
CONCORDBIO
1 min read
Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Updates

Updates Concord Biotech Limited has informed the Exchange regarding Abbreviated New Drug Application (ANDA) Approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL'. Concord Biotech Limited has informed the Exchange regarding Abbreviated New Drug Application (ANDA) Approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL'.

Read article
CONCORDBIO
CONCORDBIO
1 min read
Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Updates

Updates Concord Biotech Limited has informed the Exchange regarding Abbreviated New Drug Application (ANDA) Approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL'. Concord Biotech Limited has informed the Exchange regarding Abbreviated New Drug Application (ANDA) Approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL'.

Read article
CONCORDBIO
CONCORDBIO
1 min read
Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Company Update

Company Update We are pleased to inform that the Company has received approval from USFDA for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. We are pleased to inform that the Company has received approval from USFDA for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL.

Read article
CONCORDBIO
CONCORDBIO
1 min read
Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Company Update

Company Update We are pleased to inform that the Company has received approval from USFDA for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. We are pleased to inform that the Company has received approval from USFDA for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL.

Read article
SCC
SCC
1 min read
Market Updates Corporate announcement

Scintilla Commercial & Credit (SCC): Company Update

Company Update Please find attached newspaper clippings for board meeting held for consideration and approval of audited financial results and quarter ended 31.03.2026 Please find attached newspaper clippings for board meeting held for consideration and approval of audited financial results and quarter ended 31.03.2026

Read article
SCC
SCC
1 min read
Market Updates Corporate announcement

Scintilla Commercial & Credit (SCC): Company Update

Company Update Please find attached newspaper clippings for board meeting held for consideration and approval of audited financial results and quarter ended 31.03.2026 Please find attached newspaper clippings for board meeting held for consideration and approval of audited financial results and quarter ended 31.03.2026

Read article
TI
TI
1 min read
Market Updates Corporate announcement

Tilaknagar Industries Posts Analyst Meet Transcript on NSE

Tilaknagar Industries Limited has filed an analyst and institutional investor meet transcript with the NSE, giving market participants access to the discussion.

Read article
TI
TI
1 min read
Market Updates Corporate announcement

Tilaknagar Industries (TI): Analysts/Institutional Investor Meet/Con. Call Updates

Analysts/Institutional Investor Meet/Con. Call Updates Tilaknagar Industries Limited has informed the Exchange about Transcript Tilaknagar Industries Limited has informed the Exchange about Transcript

Read article
TI
TI
1 min read
Market Updates Corporate announcement

Tilaknagar Industries (TI): Company Update

Company Update Please find enclosed herewith Transcript of Earnings Conference Call held on May 30, 2026 for Q4 & FY 26 Results. Please find enclosed herewith Transcript of Earnings Conference Call held on May 30, 2026 for Q4 & FY 26 Results.

Read article
Plans built for every investor
TRUSTED BY INVESTORS

Track Indian stocks with ZTOX AI

NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.

RK
VJ
SM

"ZTOX alerts helped me catch a multi-bagger stock last quarter. The insider deals notifications are absolutely game-changing for retail investors."

Rahul K., Active Trader
MOST POPULAR
Basic Plan
For active market participants
₹89/mo
Includes:
Track 20 Companies
Insider deals alert
High volume alerts
Start Free
Advanced Plan
For serious investors & traders
₹119/mo
Includes:
Track 50 Companies
All Basic plan features
Block & Preferential Deals
Start Free

No credit card required. Connect WhatsApp or Telegram in minutes.

Secure connection. Your data is always protected.